CoDa Therapeutics
San Diego, US · Delaware corporation
Founders & leadership
DP
David PoolExecutive
BD
Bradford DuftExecutive
AG
Anton GopkaNamed on SEC filing
Board
JB
James BlairBoard director
GB
Geoff BrookeBoard director
JM
James MervisBoard director
MG
Mikhail GetmanBoard director
""
"Howard ""Ted""" GreeneBoard director
Reported raises · per SEC filings
Form D private placements$14.6M disclosed across 5 rounds · 2014–2020
▶$9.1MraisedJan 2021 · 3 investors · BiotechnologyRule 506(b)
▶$9.1MraisedJan 2021 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Brian LevyExecutive Officer, Director
- Pavel RodyukovDirector
- James BlairDirector
- David PoolExecutive Officer
- Offering amount
- $9.1M
- Amount sold
- $9.1M
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$754KraisedJun 2016 · 2 investors · BiotechnologyRule 506(b)
▶$754KraisedJun 2016 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Geoff BrookeDirector
- David PoolExecutive Officer
- James MervisDirector
- Bradford DuftExecutive Officer, Director
- "Howard ""Ted""" GreeneDirector
- James BlairDirector
- Inna Martin EitanDirector
- Offering amount
- $2.5M
- Amount sold
- $754K
- First sale
- Jun 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.2MraisedJun 2015 · 2 investors · BiotechnologyRule 506(b)
▶$1.2MraisedJun 2015 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- "Howard ""Ted""" GreeneDirector
- David PoolExecutive Officer
- James MervisDirector
- James BlairDirector
- Bradford DuftExecutive Officer, Director
- Geoff BrookeDirector
- Inna Martin EitanDirector
- Offering amount
- $3.4M
- Amount sold
- $1.2M
- First sale
- Jun 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1MraisedFeb 2015 · 2 investors · BiotechnologyRule 506(b)
▶$1MraisedFeb 2015 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- "Howard ""Ted""" GreeneDirector
- James BlairDirector
- David PoolExecutive Officer
- Geoff BrookeDirector
- Bradford DuftExecutive Officer, Director
- James MervisDirector
- Mikhail GetmanDirector
- Offering amount
- $3.2M
- Amount sold
- $1M
- First sale
- Feb 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.5MraisedJun 2014 · 2 investors · BiotechnologyRule 506(b)
▶$2.5MraisedJun 2014 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- James BlairDirector
- David PoolExecutive Officer
- Bradford DuftExecutive Officer, Director
- Geoff BrookeDirector
- James MervisDirector
- "Howard ""Ted""" GreeneDirector
- Anton GopkaDirector
- Offering amount
- $5.8M
- Amount sold
- $2.5M
- First sale
- May 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has CoDa Therapeutics raised?
- CoDa Therapeutics has disclosed $14.6M raised across 5 rounds.
- Where is CoDa Therapeutics headquartered?
- CoDa Therapeutics is headquartered in San Diego, US.